Prof. dr Rafet Eren je hematolog specijalizovan za limfome, akutne i hronične leukemije, multipli mijelom, mijeloproliferativne bolesti, imunsku trombocitopeniju, anemiju, talasemiju i hemofiliju. Diplomirao je na Istanbulskom medicinskom fakultetu 2007
Radovi predstavljeni na međunarodnim naučnim skupovima
- How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey – 25th Congress of EHA (2020)
- Beta Thalassemia minor: patients are not tired but depressed and anxious – 24th Congress of EHA (2019)
- Evaluation of neutrophil-lymphocyte ratio in patients with mycosis fungoides – 21st Congress of EHA (2016)
- Effect of vitamin D deficiency and replacement on endothelial functions in familial Mediterranean fever – EULAR 2014
Polypharmacy in Hematology Practice: A Single Center Experience – EHA Hemasphere (2023)
Poglavlja u knjigama
Transfusion Reactions – Current Diagnosis and Treatment in Holistic Medicine, Family Medicine, Internal Branches, Hematology, poglavlje 25, str. 1285–1286
Kikuchi-Fujimoto's Disease – Current Approaches in Hematology (2019)
Staging and Prognosis in Chronic Lymphocytic Leukemia – 2019 Update in Chronic Lymphocytic Leukemia (2019) i završio je specijalizaciju iz interne medicine na Medicinskom fakultetu Univerziteta Marmara 2012. godine. Subspecijalizaciju iz hematologije završio je 2018. godine u Obrazovnoj i istraživačkoj bolnici u Istanbulu, a 2019. godine stekao je zvanje vanrednog profesora u oblasti hematologije. Nakon toga radio je kao nastavnik u Gradskoj bolnici Başakşehir Çam ve Sakura, u Obrazovnoj i istraživačkoj bolnici Bozyaka i na Univerzitetu Istinye (Univerzitet Istinye Bahçeşehir i Liv Hospital Vadistanbul), a trenutno radi u bolnici Medicinskog fakulteta Univerziteta Biruni. Objavio je oko 50 radova u nacionalnim i međunarodnim recenziranim časopisima i član je Turskog udruženja za hematologiju, Društva za hematologiju, Turskog društva za internu medicinu i Evropskog udruženja hematologa.
Obrazovanje
-
Vanredni profesor (Klinika za hematologiju)
Obrazovna i istraživačka bolnica Prof. Dr. Cemil Taşçıoğlu
2019
-
Doktorat (Klinika za hematologiju)
Obrazovna i istraživačka bolnica u Istanbulu
2018
-
Magistarske studije (Odeljenje interne medicine)
Medicinski fakultet Univerziteta Marmara
2012
-
Osnovne studije
Univerzitet u Istanbulu, Istanbulski medicinski fakultet
2007
Akademske i administrativne funkcije
-
Vanredni profesor, dr med.
Bolnica Medicinskog fakulteta Univerziteta Biruni
2023–danas
-
Vanredni profesor, dr med.
Medicinski fakultet Univerziteta Istinye, Odeljenje interne medicine, Liv Vadistanbul Hospital
2021–2023
-
Vanredni profesor, dr med.
Obrazovna i istraživačka bolnica Bozyaka, Klinika za hematologiju
2020–2021
-
Vanredni profesor, dr med.
Gradska bolnica Başakşehir Çam ve Sakura u Istanbulu, Klinika za hematologiju
2020
-
Vanredni profesor, dr med.
Obrazovna i istraživačka bolnica Prof. Dr. Cemil Taşçıoğlu, Klinika za hematologiju
2019–2020
-
Lekar specijalista
Obrazovna i istraživačka bolnica Prof. Dr. Cemil Taşçıoğlu, Klinika za hematologiju
2018–2019
-
Lekar na subspecijalizaciji
Obrazovna i istraživačka bolnica u Istanbulu, Klinika za hematologiju
2015–2018
-
Lekar specijalista
Državna bolnica Derik u Mardinu
2013–2015
-
Lekar na specijalizaciji
Medicinski fakultet Univerziteta Marmara, Odeljenje interne medicine
2008–2012
-
Lekar opšte prakse
Zdravstvena stanica Boyaklı, Derik, Mardin
2008
-
Lekar na specijalizaciji
Univerzitet u Istanbulu, Medicinski fakultet Cerrahpaşa, Odeljenje opšte hirurgije
2007–2008
- Tursko udruženje za hematologiju
- Društvo za hematologiju
- Tursko društvo za internu medicinu
- Evropsko udruženje hematologa
-
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis
Ann Hematol · 2017 -
Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey
Leuk Lymphoma · 2019 -
The impact of bulky mass on treatment response and overall survival in patients with diffuse large b-cell lymphoma in rituximab era
UHOD · 2018 -
Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides
Ann Hematol · 2016 -
Beta Thalassemia Minor: Patients are not Tired but Depressed and Anxious
Med Princ Pract · 2020 -
Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma
Curr Med Imaging Rev · 2020 -
Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma
Transfus Apher Sci · 2017 -
Stem cell mobilization kinetics in elderly patients with multiple myeloma
Transfus Apher Sci · 2018 -
How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey
International Journal of Hematology-Oncology and Stem Cell Research · 2020 -
Prevalence of inflammatory back pain and radiologic sacroiliitis is increased in patients with primary Sjögren's syndrome
Pan Afr Med J · 2018 -
The association of mean platelet volume and platecrit and bone marrow fibrosis in patients with essential thrombocythemia: A cohort study
J Surg Med · 2019 -
The Association of Globulin Level with Treatment Response and Overall Survival in Patients with Multiple Myeloma
EJMO · 2018 -
Are We Aware of Anxiety and Depression in Patients with Newly Diagnosed Acute Leukemia?
J Gen Pract · 2017 -
Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma
Hematol Transfus Int J · 2017 -
Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
Indian J Hematol Blood Transfus · 2022 -
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
Turk J Haematol · 2021 -
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Clin Lymphoma Myeloma Leuk · 2021 -
The Effect of Serum Lactate Dehydrogenase (LDH) Level on the Response to Erythropoiesis Stimulating Agents in Patients with Low and Intermediate Risk Myelodysplastic Syndrome
J Haematol Stem Cell Res · 2021 -
Quality of life assessment with EORTC QLQ in patients with hodgkin lymphoma: Multicenter study
Acta Oncologica Turcica · 2022 -
Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival
Bull Natl Res Cent · 2022 -
Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study
Indian J Hematol Blood Transfus · 2023 -
The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?
Int J Hematol Oncol Stem Cell Res · 2023
-
Nagrada za mladog istraživača
42. nacionalni kongres hematologije
2016
-
Specijalna nagrada žirija za rad
3. kongres hematološke onkologije
2015
-
Treća nagrada za rad
2. simpozijum o hematološkoj onkologiji i transplantaciji koštane srži
2016
Hematologija
Medicinski centri ovog odeljenja
Tretmani ovog odeljenja
13- Alogena transplantacija koštane srži
- Autologna transplantacija koštane srži
- Autologna transplantacija matičnih ćelija
- Lečenje leukemije
- Lečenje limfoma
- Transplantacija koštane srži - alogena transplantacija matičnih ćelija
- Transplantacija koštane srži kod aplastične anemije
- Transplantacija koštane srži kod bolesti srpastih ćelija
- Transplantacija koštane srži kod Hodžkinovog limfoma
- Transplantacija koštane srži kod leukemije
- Transplantacija koštane srži kod limfoma
- Transplantacija koštane srži kod multiplog mijeloma
- Transplantacija koštane srži kod talasemije